BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38634357)

  • 1. Multiomics Analysis Revealed Colorectal Cancer Pathogenesis.
    Xu YJ; He Y; Chen C; Shi J; He M; Liu Y; Zhang Y; Liu Y; Zhang Y
    J Proteome Res; 2024 Jun; 23(6):2100-2111. PubMed ID: 38634357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 4. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
    Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
    Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.
    Huang Z; Huang X; Huang Y; Liang K; Chen L; Zhong C; Chen Y; Chen C; Wang Z; He F; Qin M; Long C; Tang B; Huang Y; Wu Y; Mo X; Weizhong T; Liu J
    Microbiol Spectr; 2024 May; 12(5):e0272023. PubMed ID: 38572984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism.
    Liu Z; Zhang Q; Zhang H; Yi Z; Ma H; Wang X; Wang J; Liu Y; Zheng Y; Fang W; Huang P; Liu X
    Genome Med; 2024 Jun; 16(1):77. PubMed ID: 38840170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
    Zhang Q; Zhao H; Wu D; Cao D; Ma W
    BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer.
    Yachida S; Mizutani S; Shiroma H; Shiba S; Nakajima T; Sakamoto T; Watanabe H; Masuda K; Nishimoto Y; Kubo M; Hosoda F; Rokutan H; Matsumoto M; Takamaru H; Yamada M; Matsuda T; Iwasaki M; Yamaji T; Yachida T; Soga T; Kurokawa K; Toyoda A; Ogura Y; Hayashi T; Hatakeyama M; Nakagama H; Saito Y; Fukuda S; Shibata T; Yamada T
    Nat Med; 2019 Jun; 25(6):968-976. PubMed ID: 31171880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective cohort analysis of gut microbial co-metabolism in Alaska Native and rural African people at high and low risk of colorectal cancer.
    Ocvirk S; Wilson AS; Posma JM; Li JV; Koller KR; Day GM; Flanagan CA; Otto JE; Sacco PE; Sacco FD; Sapp FR; Wilson AS; Newton K; Brouard F; DeLany JP; Behnning M; Appolonia CN; Soni D; Bhatti F; Methé B; Fitch A; Morris A; Gaskins HR; Kinross J; Nicholson JK; Thomas TK; O'Keefe SJD
    Am J Clin Nutr; 2020 Feb; 111(2):406-419. PubMed ID: 31851298
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
    Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
    J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
    Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
    BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
    Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
    Front Immunol; 2020; 11():588079. PubMed ID: 33072135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metagenomic analyses of the gut microbiota associated with colorectal adenoma.
    Saito K; Koido S; Odamaki T; Kajihara M; Kato K; Horiuchi S; Adachi S; Arakawa H; Yoshida S; Akasu T; Ito Z; Uchiyama K; Saruta M; Xiao JZ; Sato N; Ohkusa T
    PLoS One; 2019; 14(2):e0212406. PubMed ID: 30794590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 20. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
    Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
    Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.